Your browser doesn't support javascript.
loading
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study.
Seymour, John F; Ma, Shuo; Brander, Danielle M; Choi, Michael Y; Barrientos, Jacqueline; Davids, Matthew S; Anderson, Mary Ann; Beaven, Anne W; Rosen, Steven T; Tam, Constantine S; Prine, Betty; Agarwal, Suresh K; Munasinghe, Wijith; Zhu, Ming; Lash, L Leanne; Desai, Monali; Cerri, Elisa; Verdugo, Maria; Kim, Su Young; Humerickhouse, Rod A; Gordon, Gary B; Kipps, Thomas J; Roberts, Andrew W.
Afiliação
  • Seymour JF; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Victorian Comprehensive Cancer Centre, Parkville, Melbourne, VIC, Australia; Faculty of Medicine, University of Melbourne, Parkville, Melbourne, VIC, Australia. Electronic address: john.seymour@petermac.org.
  • Ma S; Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Brander DM; Duke University Medical Center, Durham, NC, USA.
  • Choi MY; University of California San Diego, San Diego, CA, USA.
  • Barrientos J; Hofstra Northwell School of Medicine, Hempstead, NY, USA.
  • Davids MS; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Anderson MA; Department of Clinical Haematology and BMT, The Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia; Division of Cancer and Haematology, The Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, VIC, Australia.
  • Beaven AW; Duke University Medical Center, Durham, NC, USA.
  • Rosen ST; City of Hope National Medical Center, Duarte, CA, USA.
  • Tam CS; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Victorian Comprehensive Cancer Centre, Parkville, Melbourne, VIC, Australia; Faculty of Medicine, University of Melbourne, Parkville, Melbourne, VIC, Australia.
  • Prine B; AbbVie, Inc, North Chicago, IL, USA.
  • Agarwal SK; AbbVie, Inc, North Chicago, IL, USA.
  • Munasinghe W; AbbVie, Inc, North Chicago, IL, USA.
  • Zhu M; AbbVie, Inc, North Chicago, IL, USA.
  • Lash LL; AbbVie, Inc, North Chicago, IL, USA.
  • Desai M; AbbVie, Inc, North Chicago, IL, USA.
  • Cerri E; AbbVie, Inc, North Chicago, IL, USA.
  • Verdugo M; AbbVie, Inc, North Chicago, IL, USA.
  • Kim SY; AbbVie, Inc, North Chicago, IL, USA.
  • Humerickhouse RA; AbbVie, Inc, North Chicago, IL, USA.
  • Gordon GB; AbbVie, Inc, North Chicago, IL, USA.
  • Kipps TJ; University of California San Diego, San Diego, CA, USA.
  • Roberts AW; Victorian Comprehensive Cancer Centre, Parkville, Melbourne, VIC, Australia; Faculty of Medicine, University of Melbourne, Parkville, Melbourne, VIC, Australia; Department of Clinical Haematology and BMT, The Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia; Division of Cancer and Haem
Lancet Oncol ; 18(2): 230-240, 2017 Feb.
Article em En | MEDLINE | ID: mdl-28089635
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article